Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Johnson & Johnson Innovation - JJDC, Inc. 13F Holdings -- Portfolio & Top Positions (2021-06-30)

Name: Johnson & Johnson Innovation - JJDC, Inc. 13F Holdings (2021-06-30)
Creator: ko.io

Johnson & Johnson Innovation - JJDC, Inc. (CIK 924020) reported $978.2M across 21 reported positions in its SEC 13F filing for 2021-06-30. Largest positions: FATE ($293.3M, 29.98%), ARWR ($270.1M, 27.61%), PTGX ($109.9M, 11.24%), CVRX ($97.9M, 10.01%), LEGN ($66.9M, 6.84%). Source: SEC Form 13F.

Rank	Ticker	Company	Value	% Portfolio	Shares	Action
1	FATE	FATE THERAPEUTICS, INC.	$293.3M	29.98%	3.4M	Hold
2	ARWR	ARROWHEAD PHARMACEUTICALS	$270.1M	27.61%	3.3M	Hold
3	PTGX	PROTAGONIST THERAPEUTICS INC.	$109.9M	11.24%	2.4M	Hold
4	CVRX	CVRX, INC.	$97.9M	10.01%	3.5M	New
5	LEGN	LEGEND BIOTECH CORPORATION	$66.9M	6.84%	1.6M	Hold
6	MGTX	MEIRAGTX HOLDINGS PLC	$44.9M	4.59%	2.9M	Hold
7	FUSN	FUSION PHARMACEUTICALS INC.	$29.7M	3.03%	3.7M	Hold
8	VOR	VOR BIOPHARMA, INC.	$20.0M	2.05%	1.1M	Hold
9	PHGE	BIOMX INC.	$11.6M	1.19%	2.1M	Hold
10	PNT	THERAPEUTICS ACQUISITION COR	$10.3M	1.05%	1.0M	New
11	ACET	ADICET BIO, INC.	$7.5M	0.77%	728,944	Hold
12	PHASQ	PHASEBIO PHARMACEUTICALS, INC.	$6.0M	0.61%	1.6M	Hold
13	ALDX	ALDEYRA THERAPEUTICS, INC.	$4.5M	0.46%	394,834	Hold
14	CSLT	CASTLIGHT HEALTH INC.	$2.1M	0.22%	811,295	Hold
15	NPCE	NEUROPACE, INC.	$1.3M	0.13%	55,435	New
16	ZY	ZYMERGEN INC.	$662,000	0.07%	16,553	New
17	TCON	TRACON PHARMACEUTICALS, INC.	$545,000	0.06%	84,003	Hold
18	CBIO	CATALYST BIOSCIENCES, INC.	$290,000	0.03%	66,951	Hold
19	GRAY	GRAYBUG VISION, INC.	$269,000	0.03%	49,547	Hold
20	LUNG	PULMONX CORPORATION	$249,000	0.03%	5,639	Hold
21	SENS	SENSEONICS HOLDINGS, INC.	$210,000	0.02%	54,621	Trimmed

Source: SEC Form 13F filings · as of 2021-06-30